CD70-driven immunosuppression in mantle cell lymphoma identifies a vulnerability to CD70-Directed bispecific antibody modalities. Yao Y, Liu Y, Yan F, Li X, et al. Cancer Lett 2026;661:218855.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yao Y, Liu Y, Yan F, Li X, et al. CD70-driven immunosuppression in mantle cell lymphoma identifies a vulnerability to CD70-Directed bispecific antibody modalities. Cancer Lett 2026;661:218855.
PMID: 42800662